L. Perrigo Company recalls Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC 45802-580-46);…
- Recall date
- May 11, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0816-2018
- FDA classification
- Class II
- Brand / firm
- L. Perrigo Company
- Sold / distributed
- Nationwide in the U.S.A.
Why it was recalled
Defective delivery system
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC 45802-580-46); c) 24-count (NDC 45802-580-62), Rx only, Mfd. by: Aveva Drug Delivery Systems, A Nitto Denko Company, Miramar, FL 33025 Distributed by Perrigo, Allegan, MI 49010
Get recall alerts
Free email alert whenever L. Perrigo Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: L. Perrigo Company